A histopathological study on the hypertrophy of the atrioventricular conduction system
Related Experiment Video
Updated: Oct 13, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Insights
Microscopical analysis of the atrioventricular (AV) conduction system reveals hypertrophy is common in various heart blocks and arrhythmias. Sclerosis of the AV node artery is particularly prevalent in sudden cardiac death cases.
Area of Science:
- Cardiovascular Pathology
- Cardiac Electrophysiology
- Histopathology
Background:
- The atrioventricular (AV) conduction system is crucial for cardiac rhythm.
- Understanding structural changes in the AV conduction system is vital for diagnosing and managing arrhythmias.
- Previous studies have indicated a link between AV conduction system abnormalities and cardiac dysfunction.
Purpose of the Study:
- To microscopically investigate hypertrophy and sclerosis within the AV conduction system in relation to various cardiac arrhythmias.
- To determine if specific patterns of hypertrophy correlate with different types of heart blocks and arrhythmias.
- To assess the incidence of AV node artery sclerosis in patients with arrhythmias, particularly sudden cardiac death.
Main Methods:
- A serial sectioning method was employed for microscopical examination.
- The study included 81 autopsied hearts, analyzing blocks from all cardiac regions.
- Histopathological analysis focused on hypertrophy of the AV conduction system components and AV node artery sclerosis.
Main Results:
- Pre-blockade and post-blockade hypertrophy of the AV conduction system were observed in significant percentages of hearts with various degrees of AV block and bundle branch block.
- Hypertrophy was prevalent in the AV conduction system across different arrhythmia groups (77%), sick sinus syndrome (42%), pre-excitation syndrome (78%), and other arrhythmias (39%).
- Hypertrophy of the proximal AV conduction system was specific to the arrhythmia group, while bundle branch hypertrophy occurred in non-arrhythmic hypertrophy or bundle branch block. Purkinje cell hypertrophy was noted in sudden cardiac death with ventricular fibrillation. AV node artery sclerosis was high in arrhythmia groups, peaking at 90% in sudden death cases.
Conclusions:
- Hypertrophy within the AV conduction system is a significant finding in patients with various cardiac blocks and arrhythmias.
- Specific locations of hypertrophy (proximal AV conduction system vs. bundle branches) may indicate different underlying conditions.
- Increased incidence of AV node artery sclerosis, especially in sudden cardiac death, suggests its role in fatal arrhythmias.
Abstract:
A microscopical study of the AV conduction system using a serial sectioning method, was performed on 81 autopsied hearts with blocks anywhere in the hearts without arrhythmia. Pre-blockade hypertrophy in the AV conduction system was seen in 38%, 38%, 50-58% corresponded respectively to 3 degrees AV block, 1-2 degrees AV block and bundle branch block (including left hemiblock). Post-blockade hypertrophy was also observed in 58%, 38% and 42-25% of the above mentioned types of blocks respectively. Hypertrophy anywhere in the AV conduction system was seen in 77%, 42%, 78%, 39%, 30% and 74% of the cases with blocks, sick sinus syndrome, pre-excitation syndrome, other arrhythmias, normal hearts and hypertrophied hearts without arrhythmia, respectively. Hypertrophy of the proximal AV conduction system to the bundle of His was specific for arrhythmia group, whereas hypertrophy of the bundle branches occurred in either hypertrophy without arrhythmia or in bundle branch block. Hypertrophy of the Purkinje cells was remarkable in sudden cardiac death by clinically-proved ventricular fibrillation. Incidence of sclerosis of the AV node artery was high in the arrhythmia group, especially the highest (90%) in the sudden death group.
Related Concept Videos
Conduction System of the Heart
This system relies on the unique properties of nodal and Purkinje cells:...
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy

